Companies: 10,795·Total market cap: $144.5T
Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics, Inc.

NWBOOTCHealthcare● Active
$0.20
$-0.01(-2.65%)
Market Cap$325545654
P/E Ratio
52W High$0.37
52W Low$0.18
Overview

Northwest Biotherapeutics, Inc. (NWBO) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · NWBO · as of Jun 10, 2026

Key Statistics

EPS (TTM)nwbo eps ttm · nwbo earnings per shareEarnings history
PE Ratio (TTM)nwbo pe ratio ttm · nwbo price to earningsPE Ratio deep dive
Revenue (TTM)nwbo revenue ttm · nwbo annual revenueFull revenue history
Dividend YieldNo Dividenddoes nwbo pay dividends · nwbo dividend yieldDividend history
Shares Outstandingnwbo shares outstanding · nwbo floatShares outstanding history
Next EarningsTBAnwbo earnings date · nwbo next earningsEarnings history

About Northwest Biotherapeutics, Inc.

CEOLinda F. Powers
IPO DateDec 14, 2001
Employees25
CountryUS
Websitenwbio.com

Northwest Biotherapeutics, Inc. (NWBO) is a biotechnology firm that creates personalized immune-based treatments for various cancers, operating both within the United States and internationally. Their…

what is northwest biotherapeutics, inc. · nwbo stock overview · northwest biotherapeutics, inc. company profile · who is northwest biotherapeutics, inc. ceo · nwbo OTC · northwest biotherapeutics, inc. headquarters · northwest biotherapeutics, inc. business segments

About Stock Overview & Key Data

Northwest Biotherapeutics, Inc. (NWBO) is a Healthcare company in the Biotechnology industry, listed on OTC since Dec 14, 2001. As of the latest trading session, NWBO stock price is $0.20, with a market capitalization of $325.5M. The stock has returned — over the past 12 months and — year-to-date.

Frequently Asked Questions

As of the latest trading session, Northwest Biotherapeutics, Inc. (NWBO) stock price is $0.20. The stock is traded on OTC under the ticker symbol NWBO. The 52-week range is $0.18 – $0.37.

NWBO stock priceNWBO quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 10, 2026Not investment advice